Webcast offers presentations on drug discovery techniques, data management, regulatory changes, and other topical issues in the world of biosciences
Life sciences organisations are faced with information requirements, consumer expectaions and competitive pressure like never before.
Balancing revenues and profits while speeding up the drug development process are top priorities in well-established pharmaceutical manufacturers as well as start up biotechnology companies.
Adding to this difficulty is increasingly complex regulatory requirements and government mandates.
EMC, IDC, and Scientific Software invite you to register and view an on-demand webcast available for a limited time.
Tune in and learn: Techniques to accelerate the drug discovery pipeline.
How to improve the way valuable data is managed and stored while lowering costs.
Improve your company's ability to adapt to regulatory changes.
Speed time to market.
How to respond rapidly to ever-changing business requirements.
Competing in the age of bioscience.
"The pharmaceutical industry is in crisis." IDC analyst Debra Goldfarb goes on to explain that the concentration of IT assets per capita in new biology organisations indicates that there are serious shortfalls of resources as there are between 6000 and 11,000 organisations in the bioscience arena.
There has been an explosion of new companies, alliances and collaborations.
This new discipline crosses more scientific boundaries than most any problem that man has ever tried to solve.
Forecasts show that the biosciences market will grow at a 24% compound annual growth through 2006 to reach nearly $38 billion.
Furthermore, there will be a fundamental shift from server investments to storage investments.
The companies that are the most successful at managing data will be the ones that survive.
Investments in IT infrastructure will pay off, as they will accelerate the drug discovery process.
Building an information infrastructure. EMC's Roberta Katz provides an interesting perspective on storage solutions that are helping customers meet their business needs including research collaboration and information sharing, data access, data mobility and scalability.
To achieve 10% sales revenue growth, top tier pharmaceutical companies must bring innovative drugs to market every six months, versus the industry average of every 27 months.
Wise investments in information infrastructure can help these companies gain the greatest benefit from the $30.5 billion they spent on research and development in 2001.
Scientific Software.
21 CFR Part 11 is on the minds of life sciences companies today.
Michael Elliott from Scientific Software discusses an application that collects, warehouses, maintains, utilises, and archives electronic records.
He details the CyberLab solution that integrates the new EMC Centera product for content addressed storage (CAS), which provides an integrated solution for protecting electronic knowledge assets while enabling 21 CFR Part 11 regulations.
Register for this free webcast at: http://mithras.itworld.com/html_newsletters/emc_biodata/index.htm l
